1. Home
  2. HDSN vs TLSI Comparison

HDSN vs TLSI Comparison

Compare HDSN & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hudson Technologies Inc.

HDSN

Hudson Technologies Inc.

HOLD

Current Price

$5.50

Market Cap

239.9M

ML Signal

HOLD

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

HOLD

Current Price

$3.30

Market Cap

270.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HDSN
TLSI
Founded
1991
2010
Country
United States
United States
Employees
N/A
102
Industry
Industrial Specialties
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
239.9M
270.2M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
HDSN
TLSI
Price
$5.50
$3.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$9.00
$7.00
AVG Volume (30 Days)
594.2K
743.8K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$237,118,000.00
N/A
Revenue This Year
$2.51
$35.45
Revenue Next Year
$2.38
$37.58
P/E Ratio
$527.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.64
$2.20
52 Week High
$10.52
$7.95

Technical Indicators

Market Signals
Indicator
HDSN
TLSI
Relative Strength Index (RSI) 51.94 43.50
Support Level $4.64 $2.20
Resistance Level $6.49 $5.41
Average True Range (ATR) 0.21 0.32
MACD 0.07 0.03
Stochastic Oscillator 96.07 71.05

Price Performance

Historical Comparison
HDSN
TLSI

About HDSN Hudson Technologies Inc.

Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

Share on Social Networks: